FAQ - Latisse

Active ingredient: bimatoprost.

Inactive ingredient: benzalkonium chloride; sodium chloride; sodium phosphate, dibasic; citric acid; and purified water. Sodium hydroxide and/or hydrochloric acid may be added to adjust pH. The pH during its shelf life ranges from 6.8 – 7.8.

Many different types of doctors can prescribe LATISSE®, including dermatologists, plastic surgeons, ophthalmologists, OB/GYNs and primary care doctors. However, not all doctors may be familiar with it. To find one who is, use the Find-A-Doctor tool.

No. LATISSE® works gradually over the 16-week treatment period. Use of LATISSE® more than once a day will not increase the growth of eyelashes. Please follow the directions, as instructed by your doctor.

To achieve the full effect of LATISSE®, you will need to use the product daily for 16 weeks. After that point, you can talk to your doctor about ongoing use.

The results you see posted in all of our Before & After Galleries are real photographs of actual LATISSE® users without mascara. Their lashes have not been retouched or altered in any way.

LATISSE® solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. Refer to the illustration below. DO NOT APPLY to the lower eyelid. If you are using other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use LATISSE® under the close supervision of your physician.

LATISSE® use may cause darkening of the eyelid skin which may be reversible. LATISSE® use may also cause increased brown pigmentation of the colored part of the eye which is likely to be permanent. While very infrequent, increased iris pigmentation has occurred when LATISSE® was administered.

It is possible for hair growth to occur in other areas of your skin that LATISSE®frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this from happening. It is also possible for a difference in eyelash length, thickness, fullness, pigmentation (darkness), number of eyelash hairs, and/or direction of eyelash growth to occur between eyes (e.g., results may vary for each eye). These differences, should they occur, will usually go away if you stop using LATISSE®.

LATISSE® solution is an ophthalmic drug product. If any gets into the eye, it is not expected to cause harm. The eye does not need to be rinsed.

This is a condition where the pressure inside the eye is higher than normal. LATISSE® may decrease IOP. So talk to your doctor if you are using IOP-lowering medications. Concurrent administration of LATISSE®and certain IOP-lowering medications in ocular hypertensive patients should be closely monitored for changes in intraocular pressure.

The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients in the clinical study. LATISSE® solution may cause other less common side effects, which typically occur on the skin close to where LATISSE®is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes and redness of the eyelids.

If LATISSE® patients develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery or develop any ocular reactions, particularly conjunctivitis and eyelid reactions; they should immediately seek their physician’s advice concerning the continued use of LATISSE® solution.